Singular Genomics Systems, Inc.

NASDAQ:OMIC

19.8 (USD) • At close January 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income -16.795-21.254-25.024-23.249-22.36-25.578-23.633-21.101-23.79-23.982-22.006-19.76-17.611-37.479-23.921-7.912-7.933-6.847-5.253
Depreciation & Amortization 1.6911.781.7221.6541.871.8821.8171.7211.6671.5421.1020.3640.3030.2550.2110.1980.1710.1390.131
Deferred Income Tax 000-1.072-1.1061.633000000.5010.9180.4462.2740.1580.0770.0250.021
Stock Based Compensation 2.1652.1862.8962.6872.7942.8423.0813.0993.3993.6053.5662.9352.8592.3411.0960.290.2710.260.239
Change In Working Capital -5.219-0.548-2.585-0.9810.11-0.81-0.564-2.38-3.575-7.15-3.7120.2252.472-5.285-0.3230.2030.697-0.1640.122
Accounts Receivables 0.257-0.3030.428-0.166-0.367-0.0180.899-0.91300000000000
Change In Inventory -0.032-0.27-1.32-2.597-1.408-0.3630.8310.306-4.484-5.991-3.31800000000
Change In Accounts Payables 0.008-0.127-0.0281.5810.180.287-1.781-1.635-0.840.2941.0130.2110.8770.6220.144-0.1430.064-0.1970.128
Other Working Capital -5.4520.152-1.6650.2011.705-0.7160.051-0.1381.749-1.453-1.4070.0141.595-5.907-0.4670.3460.6330.033-0.006
Other Non Cash Items -1.63-0.2026.5482.0591.8790.0331.365-1.2560.5130.4331.2110.0360.08323.88111.4780.0770.0520.0740.031
Operating Cash Flow -19.788-18.038-23.703-18.902-16.813-19.998-17.934-19.917-21.786-25.552-19.839-15.699-10.976-15.841-9.185-6.986-6.665-6.513-4.709
Investing Activities:
Investments In Property Plant And Equipment -0.007-0.001-0.025-0.392-0.11-0.306-0.162-1.818-1.127-2.138-0.939-1.77-1.621-0.966-0.507-0.237-0.724-0.158-0.261
Acquisitions Net 00038.327034.78-73.107-1.98936.997.868000000000
Purchases Of Investments 0-18.669-19.184-54.496-33.85-88.231-7.018-35.502-74.072-29.946-35.193-49.614-23.415-21.047-101.6080.009-4.0490-2.037
Sales Maturities Of Investments 42.342.63450.78855.5399.25753.45180.12537.49137.08222.07844.51828.05919.32710.64711.6547.88311.327.5654.694
Other Investing Activites 000-38.3270-34.7873.1071.989-36.99-7.8689.325-21.555-4.088-10.4-89.9547.8927.2717.5652.657
Investing Cash Flow 42.29323.96431.5790.651-24.703-35.08672.9450.171-38.117-10.0068.386-23.325-5.709-11.366-90.4617.6556.5477.4072.396
Financing Activities:
Debt Repayment 0000000000000.10130.50007.5
Common Stock Issued -0.0410.080.026000.6240.013000.48903.577-1.445235.662.9840.047-0.013-0.010.01
Common Stock Repurchased 0.0800-0.0060-0.006-0.007-0.450.094-0.421-0.0110-1.420000.0100
Dividends Paid 0000000000000000000
Other Financing Activities -0.1450.0800.07800.6180.0131.20.0270.090.034-2.7670.0253.4940-0.019-0.0230.010
Financing Cash Flow 00.0800.07200.6180.0060.750.0270.1010.0230.81-1.32239.154133.4840.028-0.02307.51
Other Information:
Effect Of Forex Changes On Cash 000-57.308057.308000000000000.010
Net Change In Cash 23.1056.0067.876-18.179-41.516-54.46655.017-18.996-59.876-35.457-11.43-38.214-18.005211.94733.8380.697-0.1410.8945.197
Cash At End Of Period 53.2230.11524.10916.83335.01276.528130.99475.97794.973154.849190.306201.736239.95257.95546.00812.1711.47311.61410.72